nach oben

Current Gastroenterology Reports

Erschienen in:

01.12.2021 | Esophagus (JO Clarke and NK Ahuja, Section Editors)

Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders

verfasst von: Y. Claire Dorsey, Erin J. Song, David A. Leiman

Erschienen in: Current Gastroenterology Reports | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To provide an overview of patient reported outcome measures (PROMs) and summarize their role in assessing undifferentiated dysphagia and common esophageal disorders, including achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD).

Recent Findings

Given the subjective nature of swallowing disorders, accurate diagnoses often rely on capturing the patient experience. As a result, the number of PROMs used to characterize esophageal symptoms is increasing with a recent particular emphasis on EoE. Overall, esophageal-focused PROMs are used to interpret patient symptoms and quality of life, diagnosis, and symptom changes over time. There are limitations with each instrument, including factors affecting validity, reliability, accessibility, patient participation, and logistical implementation.

Summary

PROM instruments can be helpful tools in the diagnosis and treatment of esophageal disorders. Instruments should be chosen based on factors such as target population and setting, including research, clinical, and quality improvement efforts. Future research should address how best to implement PROMs and integrate the obtained data with patient care.

Services USDoHaH. Guidance for industry patient reported outcomes measures: use in medical product development to support labeling claims. Silver Spring, MD: Food and Drug Administration; 2009.

Weldring T, Smith SM. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61–8. https://doi.org/10.4137/HSI.S11093.CrossRefPubMed

Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, et al. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11(3):193–205. https://doi.org/10.1023/a:1015291021312.CrossRefPubMed

Nilsson E, Orwelius L, Kristenson M. Patient-reported outcomes in the Swedish National Quality Registers. J Intern Med. 2016;279(2):141–53. https://doi.org/10.1111/joim.12409.CrossRefPubMed

Francis DO, McPheeters ML, Noud M, Penson DF, Feurer ID. Checklist to operationalize measurement characteristics of patient-reported outcome measures. Syst Rev. 2016;5(1):129. https://doi.org/10.1186/s13643-016-0307-4.CrossRefPubMedPubMedCentral

Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, et al. Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). Trials. 2014;15:49. https://doi.org/10.1186/1745-6215-15-49.CrossRefPubMedPubMedCentral

7.•

Patel DA, Sharda R, Hovis KL, Nichols EE, Sathe N, Penson DF et al. Patient-reported outcome measures in dysphagia: a systematic review of instrument development and validation. Dis Esophagus. 2017;30(5):1–23. https://doi.org/10.1093/dote/dow028. Systematic review of dysphagia PROMs with evaluation of each by specific domains

Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346: f167. https://doi.org/10.1136/bmj.f167.CrossRefPubMed

Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103(6):1732–8. https://doi.org/10.1016/0016-5085(92)91428-7.CrossRefPubMed

10.

Boeckxstaens GE, Annese V, des Varannes SB, Chaussade S, Costantini M, Cuttitta A et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011;364(19):1807–16. https://doi.org/10.1056/NEJMoa1010502.

11.

Ponds FA, Fockens P, Lei A, Neuhaus H, Beyna T, Kandler J, et al. Effect of Peroral Endoscopic Myotomy vs Pneumatic Dilation on Symptom Severity and Treatment Outcomes Among Treatment-Naive Patients With Achalasia: A Randomized Clinical Trial. JAMA. 2019;322(2):134–44. https://doi.org/10.1001/jama.2019.8859.CrossRefPubMedPubMedCentral

12.•

Khashab MA, Vela MF, Thosani N, Agrawal D, Buxbaum JL, Abbas Fehmi SM et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020;91(2):213–27 e6. https://doi.org/10.1016/j.gie.2019.04.231. Society guideline by the American Society for Gastrointestinal Endoscopy that uses the Eckardt score to measure outcomes to achalasia treatments

13.

Abdel Jalil AA, Katzka DA, Castell DO. Approach to the patient with dysphagia. Am J Med. 2015;128(10):1138 e17–23. https://doi.org/10.1016/j.amjmed.2015.04.026.

14.

Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, et al. Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2014;109(11):1804–14. https://doi.org/10.1038/ajg.2014.237.CrossRefPubMedPubMedCentral

15.

Grudell AB, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, et al. Validation of the mayo dysphagia questionnaire. Dis Esophagus. 2007;20(3):202–5. https://doi.org/10.1111/j.1442-2050.2007.00670.x.CrossRefPubMed

16.

Dakkak M, Bennett JR. A new dysphagia score with objective validation. J Clin Gastroenterol. 1992;14(2):99–100. https://doi.org/10.1097/00004836-199203000-00004.CrossRefPubMed

17.

Bedell A, Taft TH, Keefer L, Pandolfino J. Development of the Northwestern esophageal quality of life scale: a hybrid measure for use across esophageal conditions. Am J Gastroenterol. 2016;111(4):493–9. https://doi.org/10.1038/ajg.2016.20.CrossRefPubMedPubMedCentral

18.

Almario CV, Ballal ML, Chey WD, Nordstrom C, Khanna D, Spiegel BMR. Burden of gastrointestinal symptoms in the united states: results of a nationally representative survey of over 71,000 Americans. Am J Gastroenterol. 2018;113(11):1701–10. https://doi.org/10.1038/s41395-018-0256-8.CrossRefPubMedPubMedCentral

19.

Messerli M, Aschwanden R, Buslau M, Hersberger KE, Arnet I. Swallowing difficulties with medication intake assessed with a novel self-report questionnaire in patients with systemic sclerosis - a cross-sectional population study. Patient Prefer Adherence. 2017;11:1687–99. https://doi.org/10.2147/PPA.S142653.CrossRefPubMedPubMedCentral

20.

Almario CV, Chey WD, Khanna D, Mosadeghi S, Ahmed S, Afghani E, et al. Impact of National Institutes of Health Gastrointestinal PROMIS Measures in Clinical Practice: Results of a Multicenter Controlled Trial. Am J Gastroenterol. 2016;111(11):1546–56. https://doi.org/10.1038/ajg.2016.305.CrossRefPubMedPubMedCentral

21.

Gracie DJ, Ford AC. Editorial: Using Patient-Reported Outcome Measures in Gastroenterology: PROMISed Land or Road to Nowhere? Am J Gastroenterol. 2016;111(11):1557–8. https://doi.org/10.1038/ajg.2016.415.CrossRefPubMed

22.

McElhiney J, Lohse MR, Arora AS, Peloquin JM, Geno DM, Kuntz MM, et al. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010;25(3):221–30. https://doi.org/10.1007/s00455-009-9246-8.CrossRefPubMed

23.

DeBrosse CW, Franciosi JP, King EC, Butz BK, Greenberg AB, Collins MH, et al. Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol. 2011;128(1):132–8. https://doi.org/10.1016/j.jaci.2011.05.006.CrossRefPubMedPubMedCentral

24.

Dellon ES, Irani AM, Hill MR, Hirano I. Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis. Aliment Pharmacol Ther. 2013;38(6):634–42. https://doi.org/10.1111/apt.12413.CrossRefPubMed

25.

Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(7):742–9 e1. https://doi.org/10.1016/j.cgh.2012.03.018.

26.

Moawad FJ, Veerappan GR, Dias JA, Baker TP, Maydonovitch CL, Wong RK. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia. Am J Gastroenterol. 2013;108(3):366–72. https://doi.org/10.1038/ajg.2012.443.CrossRefPubMed

27.

Watson DI, Pike GK, Baigrie RJ, Mathew G, Devitt PG, Britten-Jones R, et al. Prospective double-blind randomized trial of laparoscopic Nissen fundoplication with division and without division of short gastric vessels. Ann Surg. 1997;226(5):642–52. https://doi.org/10.1097/00000658-199711000-00009.CrossRefPubMedPubMedCentral

28.

Bergquist H, Larsson H, Johansson L, Bove M. Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: a pilot study. Otolaryngol Head Neck Surg. 2011;145(4):551–6. https://doi.org/10.1177/0194599811409857.CrossRefPubMed

29.

Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313(18):1841–52. https://doi.org/10.1001/jama.2015.2996.CrossRefPubMed

30.

Committee NPWP, Stavropoulos SN, Desilets DJ, Fuchs KH, Gostout CJ, Haber G, et al. Per-oral endoscopic myotomy white paper summary. Gastrointest Endosc. 2014;80(1):1–15. https://doi.org/10.1016/j.gie.2014.04.014.CrossRef

31.

Cuilliere C, Ducrotte P, Zerbib F, Metman EH, de Looze D, Guillemot F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut. 1997;41(1):87–92. https://doi.org/10.1136/gut.41.1.87.CrossRefPubMed

32.

Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004;53(5):629–33. https://doi.org/10.1136/gut.2003.029298.CrossRefPubMed

33.

Werner YB, Costamagna G, Swanstrom LL, von Renteln D, Familiari P, Sharata AM, et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut. 2016;65(6):899–906. https://doi.org/10.1136/gutjnl-2014-308649.CrossRefPubMed

34.

Costantini A, Familiari P, Costantini M, Salvador R, Valmasoni M, Capovilla G, et al. Poem Versus Laparoscopic Heller Myotomy in the Treatment of Esophageal Achalasia: A Case-Control Study from Two High Volume Centers Using the Propensity Score. J Gastrointest Surg. 2020;24(3):505–15. https://doi.org/10.1007/s11605-019-04465-w.CrossRefPubMed

35.•

Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE et al. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31(9). https://doi.org/10.1093/dote/doy071. Society guidelines by the International Society for Diseases of the Esophagus that recommends the Eckardt score for diagnosis and assessment of treatment response

36.

Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108(8):1238–49; quiz 50. doi:https://doi.org/10.1038/ajg.2013.196.

37.

Shemmeri E, Aye RW, Farivar AS, Bograd AJ, Louie BE. Use of a report card to evaluate outcomes of achalasia surgery: beyond the Eckardt score. Surg Endosc. 2019. https://doi.org/10.1007/s00464-019-06952-2.CrossRefPubMed

38.

Vaezi MF, Baker ME, Achkar E, Richter JE. Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut. 2002;50(6):765–70. https://doi.org/10.1136/gut.50.6.765.CrossRefPubMedPubMedCentral

39.

Taft TH, Carlson DA, Triggs J, Craft J, Starkey K, Yadlapati R, et al. Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity. Neurogastroenterol Motil. 2018;30(6): e13287. https://doi.org/10.1111/nmo.13287.CrossRefPubMedPubMedCentral

40.•

Oude Nijhuis RAB, Prins LI, Mostafavi N, van Etten-Jamaludin FS, Smout A, Bredenoord AJ. Factors Associated With Achalasia Treatment Outcomes: Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2019. https://doi.org/10.1016/j.cgh.2019.10.008. Systematic review and meta-analysis that shows an inconclusive relationship between symptoms and treatment outcomes for achalasia

41.

Ren Y, Tang X, Chen Y, Chen F, Zou Y, Deng Z, et al. Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia. Surg Endosc. 2017;31(8):3234–41. https://doi.org/10.1007/s00464-016-5352-5.CrossRefPubMed

42.

Ferri LE, Cools-Lartigue J, Cao J, Miller L, Mayrand S, Fried GM, et al. Clinical predictors of achalasia. Dis Esophagus. 2010;23(1):76–81. https://doi.org/10.1111/j.1442-2050.2009.01006.x.CrossRefPubMed

43.

Urbach DR, Tomlinson GA, Harnish JL, Martino R, Diamant NE. A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol. 2005;100(8):1668–76. https://doi.org/10.1111/j.1572-0241.2005.50141.x.CrossRefPubMed

44.

Frankhuisen R, Heijkoop R, van Herwaarden MA, de Vries DR, Smout AJ, Baron A, et al. Validation of a disease-specific quality-of-life questionnaire in a large sample of Dutch achalasia patients. Dis Esophagus. 2008;21(6):544–50. https://doi.org/10.1111/j.1442-2050.2008.00815.x.CrossRefPubMed

45.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155(4):1022–33 e10. https://doi.org/10.1053/j.gastro.2018.07.009.

46.

Furuta GT, Katzka DA. Eosinophilic Esophagitis. N Engl J Med. 2015;373(17):1640–8. https://doi.org/10.1056/NEJMra1502863.CrossRefPubMedPubMedCentral

47.

Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150(3):581–90 e4. doi:https://doi.org/10.1053/j.gastro.2015.11.004.

48.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, et al. Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind. Double-Dummy Trial Clin Gastroenterol Hepatol. 2019. https://doi.org/10.1016/j.cgh.2019.08.050.CrossRefPubMed

49.

Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526–37, 37 e1. https://doi.org/10.1053/j.gastro.2010.07.048.

50.

Schoepfer AM, Straumann A, Panczak R, Coslovsky M, Kuehni CE, Maurer E et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147(6):1255–66 e21. https://doi.org/10.1053/j.gastro.2014.08.028.

51.

Safroneeva E, Coslovsky M, Kuehni CE, Zwahlen M, Haas NA, Panczak R, et al. Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity. Aliment Pharmacol Ther. 2015;42(8):1000–10. https://doi.org/10.1111/apt.13370.CrossRefPubMed

52.

Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE et al. Efficacy of Budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology. 2019;157(1):65–73 e5. https://doi.org/10.1053/j.gastro.2019.03.014.

53.

Schoepfer AM, Panczak R, Zwahlen M, Kuehni CE, Coslovsky M, Maurer E, et al. How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients? Am J Gastroenterol. 2015;110(3):402–14. https://doi.org/10.1038/ajg.2015.32.CrossRefPubMed

54.

Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther. 2011;34(7):790–8. https://doi.org/10.1111/j.1365-2036.2011.04791.x.CrossRefPubMed

55.•

Warners MJ, Hindryckx P, Levesque BG, Parker CE, Shackelton LM, Khanna R et al. Systematic review: disease activity indices in eosinophilic esophagitis. Am J Gastroenterol. 2017;112(11):1658–69. :https://doi.org/10.1038/ajg.2017.363. Systematic review of EoE PROMs and individual evaluation by PRO characteristics

56.

Talley NJ, Wiklund I. Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures. Qual Life Res. 2005;14(1):21–33. https://doi.org/10.1007/s11136-004-0613-5.CrossRefPubMed

57.

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20; quiz 43. https://doi.org/10.1111/j.1572-0241.2006.00630.x.

58.

Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28; quiz 29. https://doi.org/10.1038/ajg.2012.444.

59.

Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep. 2008;10(3):252–7. https://doi.org/10.1007/s11894-008-0052-5.CrossRefPubMed

60.

Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf). 2015;3(1):41–53. https://doi.org/10.1093/gastro/gou061.CrossRef

61.

Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology. 2018;154(2):267–76. https://doi.org/10.1053/j.gastro.2017.07.045.CrossRefPubMed

62.

Mermelstein J, Chait Mermelstein A, Chait MM. Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions. Clin Exp Gastroenterol. 2018;11:119–34. https://doi.org/10.2147/CEG.S121056.CrossRefPubMedPubMedCentral

63.

Jung HK, Choi MG, Baek MK, Wu JCY. Development and psychometric assessment of a self-evaluation questionnaire for gastroesophageal reflux disease. J Neurogastroenterol Motil. 2018;24(4):584–92. https://doi.org/10.5056/jnm18085.CrossRefPubMedPubMedCentral

64.

Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout A, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–62. https://doi.org/10.1136/gutjnl-2017-314722.CrossRefPubMed

65.

Modlin IM, Malfertheiner P, Hunt RH, Armstrong D, Holtmann G, Quigley EM, et al. GERD evaluation: time for a new paradigm? J Clin Gastroenterol. 2007;41(3):237–41. https://doi.org/10.1097/01.mcg.0000225693.69745.49.CrossRefPubMed

66.

Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006;295(13):1566–76. https://doi.org/10.1001/jama.295.13.1566.CrossRefPubMed

67.

Flook NW, Wiklund I. Accounting for the effect of GERD symptoms on patients’ health-related quality of life: supporting optimal disease management by primary care physicians. Int J Clin Pract. 2007;61(12):2071–8. https://doi.org/10.1111/j.1742-1241.2007.01586.x.CrossRefPubMedPubMedCentral

68.

Liker H, Hungin P, Wiklund I. Managing gastroesophageal reflux disease in primary care: the patient perspective. J Am Board Fam Pract. 2005;18(5):393–400. https://doi.org/10.3122/jabfm.18.5.393.CrossRefPubMed

69.

Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S et al. Quality of life in reflux and dyspepsia patients. psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998(583):41–9.

70.

Talley NJ, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001;96(7):1998–2004. https://doi.org/10.1111/j.1572-0241.2001.03932.x.CrossRefPubMed

71.

Kulich KR, Calabrese C, Pacini F, Vigneri S, Carlsson J, Wiklund IK. Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Investig. 2004;24(4):205–15. https://doi.org/10.2165/00044011-200424040-00002.CrossRefPubMed

72.

Kulich KR, Malfertheiner P, Madisch A, Labenz J, Bayerdorffer E, Miehlke S, et al. Psychometric validation of the German translation of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in patients with reflux disease. Health Qual Life Outcomes. 2003;1:62. https://doi.org/10.1186/1477-7525-1-62.CrossRefPubMed

73.

Engels LG, Klinkenberg-Knol EC, Carlsson J, Halling K. Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease. Health Qual Life Outcomes. 2010;8:85. https://doi.org/10.1186/1477-7525-8-85.CrossRefPubMed

74.

Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K. Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;27(11):1053–70. https://doi.org/10.1111/j.1365-2036.2008.03683.x.CrossRefPubMed

75.

Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci. 2001;46(7):1540–9. https://doi.org/10.1023/a:1010660425522.CrossRefPubMed

76.

Stanghellini V, Armstrong D, Monnikes H, Bardhan KD. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Digestion. 2007;75(Suppl 1):3–16. https://doi.org/10.1159/000101077.CrossRefPubMed

77.

Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol. 2005;100(2):442–52. https://doi.org/10.1111/j.1572-0241.2005.40122.x.CrossRefPubMed

78.

Vakil NB, Halling K, Becher A, Ryden A. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol. 2013;25(1):2–14. https://doi.org/10.1097/MEG.0b013e328358bf74.CrossRefPubMed

79.

Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(1):52–7. https://doi.org/10.1111/j.1572-0241.2001.03451.x.CrossRefPubMed

80.

Bolier EA, Kessing BF, Smout AJ, Bredenoord AJ. Systematic review: questionnaires for assessment of gastroesophageal reflux disease. Dis Esophagus. 2015;28(2):105–20. https://doi.org/10.1111/dote.12163.CrossRefPubMed

81.

Rey E, Barcelo M, Zapardiel J, Sobreviela E, Munoz M, Diaz-Rubio M. Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition? BMC Gastroenterol. 2014;14:17. https://doi.org/10.1186/1471-230x-14-17.CrossRefPubMedPubMedCentral

82.

Shaw M, Dent J, Beebe T, Junghard O, Wiklund I, Lind T, et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes. 2008;6:31. https://doi.org/10.1186/1477-7525-6-31.CrossRefPubMedPubMedCentral

83.

Aanen MC, Numans ME, Weusten BL, Smout AJ. Diagnostic value of the Reflux Disease Questionnaire in general practice. Digestion. 2006;74(3–4):162–8. https://doi.org/10.1159/000100511.CrossRefPubMed

84.

van Zanten SV, Armstrong D, Barkun A, Junghard O, White RJ, Wiklund IK. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire. Aliment Pharmacol Ther. 2007;25(9):1087–97. https://doi.org/10.1111/j.1365-2036.2007.03271.x.CrossRefPubMed

85.

Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30(10):1030–8. https://doi.org/10.1111/j.1365-2036.2009.04142.x.CrossRefPubMed

86.

Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33(10):1023–9. https://doi.org/10.1080/003655298750026697.CrossRefPubMed

87.

Netinatsunton N, Attasaranya S, Ovartlarnporn B, Sangnil S, Boonviriya S, Piratvisuth T. The value of Carlsson-dent questionnaire in diagnosis of gastroesophageal reflux disease in area with low prevalence of gastroesophageal reflux disease. J Neurogastroenterol Motil. 2011;17(2):164–8. https://doi.org/10.5056/jnm.2011.17.2.164.CrossRefPubMedPubMedCentral

88.

Young TL, Kirchdoerfer LJ, Osterhaus JT. A development and validation process for a disease-specific quality of life instrument. Drug Inf J. 1996;30(1):185–93. https://doi.org/10.1177/009286159603000122.CrossRef

89.

Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, Scott-Lennox J, Holverson HE, et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract. 1995;41(2):126–36.PubMed

90.

Allen CJ, Parameswaran K, Belda J, Anvari M. Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus. 2000;13(4):265–70. https://doi.org/10.1046/j.1442-2050.2000.00129.x.CrossRefPubMed

91.

Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis. 1998;16(5):315–24. https://doi.org/10.1159/000016881.CrossRefPubMed

92.

Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci. 1995;40(3):584–9. https://doi.org/10.1007/bf02064375.CrossRefPubMed

93.

Pare P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol. 2003;17(5):307–12. https://doi.org/10.1155/2003/530984.CrossRefPubMed

94.

Armstrong D, Monnikes H, Bardhan KD, Stanghellini V. The construction of a new evaluative GERD questionnaire–methods and state of the art. Digestion. 2007;75(Suppl 1):17–24. https://doi.org/10.1159/000101078.CrossRefPubMed

95.

Rubin G, Uebel P, Brimo-Hayek A, Hey KH, Doerfler H, Heading RC. Validation of a brief symptom questionnaire (ReQuest in Practice) for patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2008;27(9):846–51. https://doi.org/10.1111/j.1365-2036.2008.03641.x.CrossRefPubMed

96.

Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroenterol. 2007;41(5):437–44. https://doi.org/10.1097/MCG.0b013e31802e849f.CrossRefPubMed

97.

Monnikes H, Bardhan KD, Stanghellini V, Berghofer P, Bethke TD, Armstrong D. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion. 2004;69(4):238–44. https://doi.org/10.1159/000079708.

98.

Bardhan KD, Stanghellini V, Armstrong D, Berghofer P, Gatz G, Monnikes H. International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease. Digestion. 2007;75(Suppl 1):48–54. https://doi.org/10.1159/000101082.CrossRefPubMed

99.

Prodinger B, Taylor P. Improving quality of care through patient-reported outcome measures (PROMs): expert interviews using the NHS PROMs Programme and the Swedish quality registers for knee and hip arthroplasty as examples. BMC Health Serv Res. 2018;18(1):87. https://doi.org/10.1186/s12913-018-2898-z.CrossRefPubMedPubMedCentral

100.

Chung AE, Sandler RS, Long MD, Ahrens S, Burris JL, Martin CF, et al. Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn’s and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners). J Am Med Inform Assoc. 2016;23(3):485–90. https://doi.org/10.1093/jamia/ocv191.CrossRefPubMedPubMedCentral

101.

McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling Dysphagia. 2000;15(3):122–33. https://doi.org/10.1007/s004550010013.CrossRefPubMed

102.

Wallace KL, Middleton S, Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology. 2000;118(4):678–87. https://doi.org/10.1016/s0016-5085(00)70137-5.CrossRefPubMed

103.

Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73. https://doi.org/10.1016/j.ejca.2007.07.005.CrossRefPubMed

104.

Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer. 2003;39(10):1384–94. https://doi.org/10.1016/s0959-8049(03)00270-3.CrossRefPubMed

Titel: Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders
verfasst von: Y. Claire Dorsey
Erin J. Song
David A. Leiman
Publikationsdatum: 01.12.2021
Verlag: Springer US
Erschienen in: Current Gastroenterology Reports / Ausgabe 12/2021
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-021-00831-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

The Management of the Hospitalized Ulcerative Colitis Patient, the Medical—Surgical Conundrum

When Pandemics Collide: the Interplay of Obesity and COVID-19

Portal Vein Thrombosis In Cirrhosis: Interventional Treatment Options

Innovations in Screening Tools for Barrett’s Esophagus and Esophageal Adenocarcinoma

How I Approach Laryngopharyngoesophageal Reflux (LPR)

Newborn Screening for Biliary Atresia: a Review of Current Methods

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin